Neurocrine Biosciences, Inc. NBIX
164.63 USD +4.87 (+3.05%)
At closeNov 6, 2026, 4:27 PM EST
164.63 0.00 0.00%
After hours · Nov 6, 4:27 PM ET
158.66 Day range 165.86
123.10 52-week range 185.50
- YTD
- +16.08%
- 1 year
- +6.35%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 2.86B | 2.36B | 1.89B | 1.49B | 1.13B | |
| 2.86B | 2.36B | 1.89B | 1.49B | 1.13B | |
| 52.10M | 34.00M | 39.70M | 23.20M | 14.30M | |
| 2.81B | 2.32B | 1.85B | 1.47B | 1.12B | |
| 2.19B | 1.75B | 1.60B | 1.22B | 1.02B | |
| 1.02B | 731.10M | 565.00M | 463.80M | 328.10M | |
| 1.16B | 1.01B | 887.60M | 752.70M | 583.30M | |
| 619.10M | 570.50M | 250.90M | 249.00M | 102.50M | |
| 226.80M | 144.70M | 82.40M | 59.40M | 11.80M | |
| 478.60M | 341.30M | 249.70M | 154.50M | 89.60M | |
| 478.60M | 341.30M | 249.70M | 154.50M | 89.60M | |
| 478.60M | 341.30M | 249.70M | 154.50M | 89.60M | |
| 478.60M | 341.30M | 249.70M | 154.50M | 89.60M | |
| 4.81 | 3.40 | 2.56 | 1.61 | 0.95 | |
| 4.81 | 3.40 | 2.56 | 1.61 | 0.95 | |
| 4.67 | 3.29 | 2.47 | 1.56 | 0.92 | |
| 705.40M | 486.00M | 332.10M | 213.90M | 127.20M | |
| 705.40M | 486.00M | 332.10M | 213.90M | 127.20M | |
| 99.50M | 100.40M | 97.70M | 95.80M | 94.60M | |
| 102.50M | 103.70M | 101.00M | 98.90M | 97.90M |